Insys Therapeutic (Nasdaq:INSY) is a commercial-stage specialty pharmaceutical company which mostly focuses on pain management products. It has a market cap of $673 million, and is not profitabl.. Guest Devin Shutte from The Robert Group and resident expert Paul Theron from Vestact decide whether Insys Therapeutic is hot or not.